Skip to content

Clinical trials

Phase 1 Stomach Neoplasms trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stomach Neoplasms Phase: Phase 1 Country / region: France Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20122
20151
20162
20172
20181
20194
20203
20212
20224
20231
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated7
Active, not recruiting6
Recruiting5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Seagen, a wholly owned subsidiary of Pfizer3
AbbVie2
Amgen2
Eli Lilly and Company2
Seagen Inc.2
Black Diamond Therapeutics, Inc.1
Boehringer Ingelheim1
Bristol-Myers Squibb1
Exelixis1
GlaxoSmithKline1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stomach Neoplasms27
Carcinoma, Non-Small-Cell Lung18
Colorectal Neoplasms12
Ovarian Neoplasms11
Neoplasms9
Endometrial Neoplasms8
Neoplasm Metastasis8
Squamous Cell Carcinoma of Head and Neck8
Breast Neoplasms7
Carcinoma, Hepatocellular7

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.